Comparison of High Flow Nasal Oxygen and Nasal Cannula in Burn Patients Under Sedation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAnkara City Hospital Bilkent

About this trial

Burn-related pain is severe and often difficult to manage. Burn patients often require high doses of opioids and anxiolytics. Anesthetic agents used during sedation such as benzodiazepines, propofol and opioids can cause respiratory depression, predisposing patients to hypoventilation and hypoxemia due to airway obstruction. Oxygen is administered to patients with a standard nasal cannula during sedation. High Flow Nasal Oxygen (HFNO) helps to improve the oxygenation of patients with respiratory distress by delivering high flow humidified oxygen through the nasal cannula at a high rate of up to 40-70 liters per minute. The aim of this study was to compare the effects of HFNO and nasal oxygen therapy in preventing hypoxemia in deeply sedated burn patients.

Eligibility criteria

Qualifiers

None

Disqualifiers

Intubation

Tracheostomies

Need for oxygen therapy due to preexisting disease

Pregnancy

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

70 Participants
are grouped into 2 trial groups

Sponsors and collaborators